BeStock  
Stocks › AQST

Aquestive Therapeutics AQST

US equityMarket cap rank #3645
$4.62 +$0.01 (+0.22%)
Pre-market · Oct 8, 7:30 am ET · After hours $4.62 0.00%
Open$4.58
Prev close$4.61
Day range$4.53 – $4.67
Volume1.36M
Market cap$579.86M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$13.82M+38.1% YoY
Operating profit-$8.22M+27.7% YoY
Net profit-$22.86M-68.8% YoY
Diluted EPS-$0.18-28.6% YoY
Free cash flow-$9.65M-20.3% YoY
Operating cash flow-$9.44M

Revenue, last 8 quarters

$13.5MSep '24$11.9MDec '24$8.7MMar '25$10.0MJun '25$12.8MSep '25$13.0MDec '25$14.4MMar '26$13.8MJun '26

Net profit, last 8 quarters

$-11.5MSep '24$-17.1MDec '24$-22.9MMar '25$-13.5MJun '25$-15.4MSep '25$-31.9MDec '25$-8.1MMar '26$-22.9MJun '26

Diluted EPS by quarter

-0.13Sep '24-0.19Dec '24-0.24Mar '25-0.14Jun '25-0.14Sep '25-0.26Dec '25-0.07Mar '26-0.18Jun '26

Free cash flow by quarter

$-12.0MSep '24$-6.5MDec '24$-23.5MMar '25$-8.0MJun '25$-12.9MSep '25$-8.6MDec '25$-14.9MMar '26$-9.7MJun '26

Annual revenue

$45.8MFY20$50.8MFY21$47.7MFY22$50.6MFY23$57.6MFY24$44.5MFY25

Profitability & balance sheet

Gross margin67.0%
Operating margin-97.5%
Net margin-144.6%
Return on assets-69.3%
Current ratio7.19
Liabilities / assets142.8%
Cash & investments$98.49M
Total debt$58.21M
Net cash (debt)$40.28M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $13.82M $14.45M $44.55M $13.02M $12.81M
Total Operating Revenue $13.82M $14.45M $44.55M $13.02M $12.81M
Cost of Revenue $4.02M $3.47M $18.56M $5.84M $4.51M
Gross Profit $9.80M $10.98M $25.99M $7.18M $8.30M
Operating Expense $18.03M $15.18M $97.04M $36.02M $19.78M
Selling and Admin Expenses $14.06M $10.98M $79.85M $32.82M $15.25M
Research & Development $3.96M $4.20M $17.19M $3.20M $4.53M
Operating Profit -$8.22M -$4.20M -$71.05M -$28.84M -$11.48M
Net Non-Operating Interest Income (Expense) -$2.96M -$3.85M -$12.73M -$3.02M -$3.97M
Non-Operating Interest Income $882,000.00 $83,000.00 $4.37M $1.25M $306,000.00
Non-Operating Interest Expense $3.84M $3.94M $17.10M $4.27M $4.27M
Other Income (Expense) -$11.68M – – – –
Special Income (Charges) -$11.68M – – – –
-Less:Other Special Charges $11.68M – – – –
Pretax Profit -$22.86M -$8.06M -$83.78M -$31.86M -$15.45M
Net Profit -$22.86M -$8.06M -$83.78M -$31.86M -$15.45M
Profit from Continuing Operations -$22.86M -$8.06M -$83.78M -$31.86M -$15.45M
Net Income to Parent Company -$22.86M -$8.06M -$83.78M -$31.86M -$15.45M
Net Income to Common Stockholders -$22.86M -$8.06M -$83.78M -$31.86M -$15.45M
Basic EPS -$0.18 -$0.07 -$0.78 -$0.26 -$0.14
Diluted EPS -$0.18 -$0.07 -$0.78 -$0.26 -$0.14
Tax – – $0.00 – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $132.10M $141.13M $160.43M $160.43M $163.56M
Total Current Assets $118.49M $130.18M $149.27M $149.27M $151.67M
Cash and Cash Equivalents & Short-Term Investments $98.49M $110.73M $121.17M $121.17M $129.06M
-Cash and Cash Equivalents $98.49M $110.73M $121.17M $121.17M $129.06M
Receivables $9.33M $6.87M $17.76M $17.76M $11.80M
-Accounts Receivable $7.72M $5.26M $8.01M $8.01M $9.48M
-Other Receivables $1.61M $1.61M $10.33M $10.33M $2.32M
-Receivables Adjustments Allowances $0.00 $0.00 -$582,000.00 -$582,000.00 $0.00
Inventory $7.37M $8.07M $6.17M $6.17M $7.88M
Other Current Assets $3.31M $4.52M $4.17M $4.17M $2.93M
Total Non-Current Assets $13.61M $10.94M $11.16M $11.16M $11.89M
Net PPE $11.91M $8.31M $8.51M $8.51M $8.69M
-Gross PPE $56.17M $52.43M $52.54M $52.54M $52.59M
-Accumulated Depreciation -$44.26M -$44.13M -$44.02M -$44.02M -$43.90M
Non Current Accounts Receivables $1.00M $2.00M $2.00M $2.00M $2.00M
Other Non-Current Assets $701,000.00 $635,000.00 $642,000.00 $642,000.00 $1.20M
Total Liabilities $188.69M $175.18M $194.09M $194.09M $167.67M
Total Current Liabilities $16.48M $31.75M $47.61M $47.61M $25.57M
Payables $9.29M $12.30M $30.21M $30.21M $11.28M
-Accounts Payable $8.97M $11.89M $29.86M $29.86M $10.87M
-Total Tax Payable $328,000.00 $408,000.00 $349,000.00 $349,000.00 $410,000.00
Current Accrued Expenses $968,000.00 $972,000.00 $973,000.00 $973,000.00 $1.02M
Short-Term Debt and Capital Lease Obligation $852,000.00 $14.32M $10.63M $10.63M $6.93M
-Current Debt $32,000.00 $13.66M $9.99M $9.99M $6.33M
-Current Capital Lease Obligation $820,000.00 $662,000.00 $631,000.00 $631,000.00 $601,000.00
Current Deferred Liabilities $1.09M $1.09M $1.09M $1.09M $1.09M
Other Current Liabilities $1.05M $1.00M $1.00M $1.00M $1.56M
Total Non-Current Liabilities $172.21M $143.43M $146.48M $146.48M $142.09M
Long Term Debt and Capital Lease Obligation $58.18M $29.26M $31.86M $31.86M $34.45M
-Long Term Debt $50.65M $25.10M $27.52M $27.52M $29.94M
-Long Term Capital Lease Obligation $7.53M $4.16M $4.34M $4.34M $4.51M
Non-Current Deferred Liabilities $18.85M $19.12M $19.39M $19.39M $19.66M
Other Non-Current Liabilities $34.02M $32.97M $33.21M $33.21M $26.01M
Total Equity -$56.59M -$34.05M -$33.66M -$33.66M -$4.11M
Stockholders' Equity -$56.59M -$34.05M -$33.66M -$33.66M -$4.11M
Capital Stock $126,000.00 $124,000.00 $122,000.00 $122,000.00 $121,000.00
-Common Stock $126,000.00 $124,000.00 $122,000.00 $122,000.00 $121,000.00
Additional Paid-In Capital $421.21M $420.88M $413.21M $413.21M $410.91M
Retained Earnings -$477.92M -$455.06M -$447.00M -$447.00M -$415.14M
Goodwill and Other Intangible Assets – – – – $0.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$9.44M -$14.81M -$52.43M -$8.47M -$12.65M
Net cash flow from continuing operations -$9.44M -$14.81M -$52.43M -$8.47M -$12.65M
Net Income from Continuing Operations -$22.86M -$8.06M -$83.78M -$31.86M -$15.45M
Depreciation & Depletion & Amortization $136,000.00 $113,000.00 $548,000.00 $130,000.00 $139,000.00
Other Non-Cash Items $1.81M $3.21M $11.00M $2.75M $2.76M
Change in Working Capital -$3.10M -$12.39M $12.18M $19.14M -$2.88M
-Change in Receivables -$2.46M $10.90M -$10.37M -$5.96M $63,000.00
-Change in Inventory $706,000.00 -$1.90M -$126,000.00 $1.71M $241,000.00
-Change in Prepaid Assets $2.14M -$340,000.00 $698,000.00 -$685,000.00 -$1.72M
-Change in Payables and Accrued Expense -$3.21M -$20.78M $22.56M $24.34M -$1.19M
-Change In Other Working Capital -$273,000.00 -$272,000.00 -$571,000.00 -$272,000.00 -$273,000.00
Net cash flow from investing -$212,000.00 -$52,000.00 -$562,000.00 -$85,000.00 -$235,000.00
Net Cash Flow from Continuing Investing Activities -$212,000.00 -$52,000.00 -$562,000.00 -$85,000.00 -$235,000.00
Capital Expenditure -$212,000.00 -$52,000.00 -$562,000.00 -$85,000.00 -$235,000.00
Financing Cash Flow -$2.59M $4.42M $102.62M $660,000.00 $81.41M
Net Cash Flow from Continuing Financing Activities -$2.59M $4.42M $102.62M $660,000.00 $81.41M
Net Issuance Payments Of Debt $5.44M -$8,000.00 -$26,000.00 -$5,000.00 -$7,000.00
Net Common Stock Issuance -$79,000.00 $4.76M $100.65M -$301,000.00 $79.72M
Proceeds from Stock Option Exercised $759,000.00 $1,000.00 $2.81M $984,000.00 $1.77M
Net Other Financing Charges -$8.71M -$329,000.00 -$821,000.00 -$18,000.00 -$70,000.00
Ending Cash Balance $98.49M $110.73M $121.17M $121.17M $129.06M
Net Change in Cash -$12.24M -$10.44M $49.62M -$7.89M $68.53M
Beginning Cash Balance $110.73M $121.17M $71.55M $129.06M $60.54M
Free Cash Flow -$9.65M -$14.86M -$52.99M -$8.55M -$12.88M

Discussion

No comments yet — be the first to weigh in on AQST.

Leave a comment

Scroll to Top